Rifampin
Who holds supplier records for Rifampin? 5 organisations hold a current record for Rifampin: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), South (1) and India (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Rifampin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rifampin
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Rifampin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 13796, 36879 · latest filing Apr 2022
- CKD BIO CORPSouthCEPActive DMF 13663 · latest filing Sept 1998
- EUROAPI ITALY SRLItaly Company GMP cert on recordActive DMF 13383 · latest filing Sept 1998
- Lupin LimitedIndia Company GMP cert on recordActive DMF 13214 · latest filing Apr 1998
- ZHENGZHOU MINZHONG PHARMACEUTICAL CO LTDActive DMF 44814 · latest filing Sept 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (2)
Certificates of Suitability on the EDQM register for Rifampin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CKD BIO CORP. Ansan-Si | KR | CEP 2024-204 - Rev 00 Rifampicin | Sept 2026 | Inspected Sept 2023 Italy, outside 3-year window |
| OLON S.P.A. Rodano | IT | CEP 2009-275 - Rev 06 Rifampicin | Feb 2026 | Inspected Mar 2025 Italy |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Rifampin are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- FERMIC SA DE CVInactive DMF 13717 · filed Sept 1998
- United States · Inactive DMF 13398 · filed Sept 1998
- SICHUAN LONG MARCH PHARMACEUTICAL CO LTDInactive DMF 13644 · filed Sept 1998
- SOLCHEM ITALIANA S P AInactive DMF 10027 · filed Dec 1992
- SYNTHO RIFA PVT LTDInactive DMF 7603 · filed Jul 1988
Overview
Rifampin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL374478).
Chemical identity
- IUPAC name
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- Canonical SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
- InChIKey
- JQXXHWHPUNPDRT-WLSIYKJHSA-N
- Synonyms
- Abrifam, BA 411661E, BA 41166/E, BA-41166/E, BA-41166E, Eremfat, L-5103, L-5103 LEPETIT, L-5103-LEPETIT, NIH-10782, NSC-113926, Rifa
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Rifamycin Antibacterial
- Chemical structure
- Rifamycins
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Rifampin?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Rifampin: OLON SPA (Italy), CKD BIO CORP (South), EUROAPI ITALY SRL (Italy), Lupin Limited (India) and ZHENGZHOU MINZHONG PHARMACEUTICAL CO LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Rifampin Drug Master Files are active?
OLON SPA (DMF 13796, 36879), CKD BIO CORP (DMF 13663), EUROAPI ITALY SRL (DMF 13383), Lupin Limited (DMF 13214) and ZHENGZHOU MINZHONG PHARMACEUTICAL CO LTD (DMF 44814). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Rifampin records mean?
5 organisations have only inactive Type II DMFs for Rifampin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Rifampin have a European Certificate of Suitability?
Yes. 2 organisations hold a valid CEP for Rifampin on the EDQM register, including CKD BIO CORP. Ansan-Si (KR) and OLON S.P.A. Rodano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Rifampin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Rifampin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.